Broad Consent for Research With Biological Samples: Workshop Conclusions

Christine Grady(National Institutes of Health Clinical Center), Lisa Eckstein(University of Tasmania), Ben Berkman(National Human Genome Research Institute), Dan W. Brock(Harvard University), Robert Cook‐Deegan, Stephanie M. Fullerton(University of Washington), Hank Greely(Stanford Medicine), Mats Hansson(Uppsala University), Sara Chandros Hull, Scott Y. H. Kim(National Institutes of Health Clinical Center), Bernie Lo(Greenwall Foundation), Rebecca D. Pentz(Emory University), Laura Lyman Rodriguez(National Human Genome Research Institute), Carol J. Weil, Benjamin S. Wilfond(Seattle Children's Hospital), David Wendler(National Institutes of Health Clinical Center)
The American Journal of Bioethics
August 25, 2015
Cited by 336Open Access
Full Text

Abstract

Different types of consent are used to obtain human biospecimens for future research. This variation has resulted in confusion regarding what research is permitted, inadvertent constraints on future research, and research proceeding without consent. The National Institutes of Health (NIH) Clinical Center's Department of Bioethics held a workshop to consider the ethical acceptability of addressing these concerns by using broad consent for future research on stored biospecimens. Multiple bioethics scholars, who have written on these issues, discussed the reasons for consent, the range of consent strategies, and gaps in our understanding, and concluded with a proposal for broad initial consent coupled with oversight and, when feasible, ongoing provision of information to donors. This article describes areas of agreement and areas that need more research and dialogue. Given recent proposed changes to the Common Rule, and new guidance regarding storing and sharing data and samples, this is an important and timely topic.


Related Papers

No related papers found

Powered by citation graph analysis